These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18760600)

  • 21. Potential nicotinic acetylcholine receptor ligands from 2,4-methanoproline derivatives.
    Patel AB; Malpass JR
    J Med Chem; 2008 Nov; 51(21):7005-9. PubMed ID: 18841955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyrazole derivatives as partial agonists for the nicotinic acid receptor.
    van Herk T; Brussee J; van den Nieuwendijk AM; van der Klein PA; IJzerman AP; Stannek C; Burmeister A; Lorenzen A
    J Med Chem; 2003 Aug; 46(18):3945-51. PubMed ID: 12930155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of pyrazolyl propionyl cyclohexenamide derivatives as full agonists for the high affinity niacin receptor GPR109A.
    Ding FX; Shen HC; Wilsie LC; Krsmanovic ML; Taggart AK; Ren N; Cai TQ; Wang J; Tong X; Holt TG; Chen Q; Waters MG; Hammond ML; Tata JR; Colletti SL
    Bioorg Med Chem Lett; 2010 Jun; 20(11):3372-5. PubMed ID: 20452209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Agonist lead identification for the high affinity niacin receptor GPR109a.
    Gharbaoui T; Skinner PJ; Shin YJ; Averbuj C; Jung JK; Johnson BR; Duong T; Decaire M; Uy J; Cherrier MC; Webb PJ; Tamura SY; Zou N; Rodriguez N; Boatman PD; Sage CR; Lindstrom A; Xu J; Schrader TO; Smith BM; Chen R; Richman JG; Connolly DT; Colletti SL; Tata JR; Semple G
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4914-9. PubMed ID: 17588745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel treatment target for Parkinson's disease.
    Wakade C; Chong R
    J Neurol Sci; 2014 Dec; 347(1-2):34-8. PubMed ID: 25455298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pyrazole acids as niacin receptor agonists for the treatment of dyslipidemia.
    Schmidt D; Smenton A; Raghavan S; Carballo-Jane E; Lubell S; Ciecko T; Holt TG; Wolff M; Taggart A; Wilsie L; Krsmanovic M; Ren N; Blom D; Cheng K; McCann PE; Gerard Waters M; Tata J; Colletti S
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4768-72. PubMed ID: 19592242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of a novel class of PPARdelta partial agonists.
    Shearer BG; Patel HS; Billin AN; Way JM; Winegar DA; Lambert MH; Xu RX; Leesnitzer LM; Merrihew RV; Huet S; Willson TM
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5018-22. PubMed ID: 18722772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of novel pyrrole derivatives as potent agonists for the niacin receptor GPR109A.
    Miyazawa Y; Yamaguchi T; Yamaguchi M; Tago K; Tamura A; Sugiyama D; Aburatani T; Nishizawa T; Kurikawa N; Kono K
    Bioorg Med Chem Lett; 2020 May; 30(10):127105. PubMed ID: 32199732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular modeling of A1 and A2A adenosine receptors: comparison of rhodopsin- and beta2-adrenergic-based homology models through the docking studies.
    Yuzlenko O; Kieć-Kononowicz K
    J Comput Chem; 2009 Jan; 30(1):14-32. PubMed ID: 18496794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acyl hydroxypyrazoles as novel agonists for high-affinity nicotinic acid receptor GPR109A: WO2008051403.
    Shen HC
    Expert Opin Ther Pat; 2009 Aug; 19(8):1149-55. PubMed ID: 19566484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design of novel alpha7-subtype-preferring nicotinic acetylcholine receptor agonists: application of docking and MM-PBSA computational approaches, synthetic and pharmacological studies.
    Grazioso G; Pomè DY; Matera C; Frigerio F; Pucci L; Gotti C; Dallanoce C; De Amici M
    Bioorg Med Chem Lett; 2009 Nov; 19(22):6353-7. PubMed ID: 19804970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel patent publications on high-affinity nicotinic acid receptor agonists.
    Shen HC; Colletti SL
    Expert Opin Ther Pat; 2009 Jul; 19(7):957-67. PubMed ID: 19552512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rigid analogs of DMPP as probes for the nicotinic receptors.
    Guandalini L; Martini E; Martelli C; Romanelli MN; Varani K
    Farmaco; 2005 Feb; 60(2):99-104. PubMed ID: 15752468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complementary three-dimensional quantitative structure-activity relationship modeling of binding affinity and functional potency: a study on alpha4beta2 nicotinic ligands.
    Tosco P; Ahring PK; Dyhring T; Peters D; Harpsøe K; Liljefors T; Balle T
    J Med Chem; 2009 Apr; 52(8):2311-6. PubMed ID: 19301898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insights into docking and scoring neuronal alpha4beta2 nicotinic receptor agonists using molecular dynamics simulations and QM/MM calculations.
    Sgrignani J; Bonaccini C; Grazioso G; Chioccioli M; Cavalli A; Gratteri P
    J Comput Chem; 2009 Nov; 30(15):2443-54. PubMed ID: 19360794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SAR of α7 nicotinic receptor agonists derived from tilorone: exploration of a novel nicotinic pharmacophore.
    Schrimpf MR; Sippy KB; Briggs CA; Anderson DJ; Li T; Ji J; Frost JM; Surowy CS; Bunnelle WH; Gopalakrishnan M; Meyer MD
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1633-8. PubMed ID: 22281189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-activity relationships of GPR120 agonists based on a docking simulation.
    Sun Q; Hirasawa A; Hara T; Kimura I; Adachi T; Awaji T; Ishiguro M; Suzuki T; Miyata N; Tsujimoto G
    Mol Pharmacol; 2010 Nov; 78(5):804-10. PubMed ID: 20685848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potent tricyclic pyrazole tetrazole agonists of the nicotinic acid receptor (GPR109a).
    Boatman PD; Schrader TO; Kasem M; Johnson BR; Skinner PJ; Jung JK; Xu J; Cherrier MC; Webb PJ; Semple G; Sage CR; Knudsen J; Chen R; Taggart AK; Carballo-Jane E; Richman JG
    Bioorg Med Chem Lett; 2010 May; 20(9):2797-800. PubMed ID: 20363624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for constitutive dimerization of niacin receptor subtypes.
    Mandrika I; Petrovska R; Klovins J
    Biochem Biophys Res Commun; 2010 Apr; 395(2):281-7. PubMed ID: 20380810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery and structure-activity relationship of quinuclidine benzamides as agonists of alpha7 nicotinic acetylcholine receptors.
    Bodnar AL; Cortes-Burgos LA; Cook KK; Dinh DM; Groppi VE; Hajos M; Higdon NR; Hoffmann WE; Hurst RS; Myers JK; Rogers BN; Wall TM; Wolfe ML; Wong E
    J Med Chem; 2005 Feb; 48(4):905-8. PubMed ID: 15715459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.